The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Joint Dissenting Statement of Commissioners Rohit Chopra and Rebecca Kelly Slaughter Regarding the Vertical Merger Commentary
Statement of Commissioners Phillips and Wilson Regarding the Commentary on Vertical Merger Enforcement
Statement of Commissioner Chopra Regarding the FTC EnergyGuide Rule
20210640: RB CNS AIV B, LP; Charles R. Bushong
20210550: Odyssey Investment Partners Fund VI, L.P.; Audax Private Equity Fund V-A, L.P
20210590: Amy Adams Strunk; KSA Industries, Inc
20210613: NovaQuest Private Equity Fund I, L.P.; CoreRX, Inc.
20210616: FedEx Corporation; ShopRunner, Inc.
16 CFR Part 432: Trade Regulation Rule Relating to Power Output Claims for Amplifiers Utilized in Home Entertainment Products
Stryker and Wright Medical, In the Matter of
The Federal Trade Commission required medical device companies Stryker Corp. and Wright Medical Group N.V. to divest all assets related to Stryker’s total ankle replacements and finger joint implant products to remedy concerns, as alleged in the complaint, that Stryker’s proposed $4 billion acquisition of Wright would harm competition in these two markets. Under the consent order, Stryker and Wright must divest all assets associated with Stryker’s total ankle replacements and finger joint implants to DJO Global, allowing it to become an independent, viable, and effective competitor in these markets. After a period for public comment, the Commission issued its final order on December 11, 2020.